| Full Schedule | ||
| Date/Time | Session | Room |
| 5/2/2019 8:20 AM -to- 8:50 AM | Welcome |
Room 1 |
| 5/2/2019 8:50 AM -to- 9:00 AM | Keynote / Welcome Address Troy Dayton Keynote/Welcome Address Interview with Troy Dayton, CEO of the Arcview Group. Troy covers the Cannabis space and shares some of his insights into the sector and where he believes the industry is headed! Also speaks to how investors can get involved with the Arcview Group.  |
Room 1 |
| 5/2/2019 9:00 AM -to- 9:30 AM | Hemptown USA Damien Lowry Hemptown USA Growing feminized hemp outdoors can only be learned one way. Doing it. That’s what the Wolterman family set out to accomplish years ago when they purchased an equestrian ranch in Central Point, Oregon and began converting it to a fully functioning hemp farm. Every square inch of that farm became a valuable lesson – in everything from genetics and field-prep to irrigation and processing. The team’s perseverance resulted in a recent crop yield exceeding 110,000 pounds with full spectrum cannabinoid content hovering between 14 and 17%. Estimates for 2019 have us on track for closer to one million pounds. It’s no secret the hemp plant has always had the power to improve lives and change the world. Through our continued hard work, products and education it’s Hemptown USA’s mission to deliver on that promise.  |
Room 1 |
| 5/2/2019 9:30 AM -to- 10:00 AM | 4Front Ventures | CSE: CNNX Kris Krane 4Front Ventures | CSE: CNNX 4Front is setting new standards in the cannabis industry and has the vision and scope to drive change at every touchpoint on the supply and demand chain. If you’re going to lead, you have to think big. When we began as consultants, 4Front brought together some of the best minds in this industry and others — finance, real estate, retail and agriculture — and earned a reputation for winning, helping partners earn more than 50 medical cannabis licenses nationwide. Today we think even bigger, with a 360° view of the industry, and the assets to impact it: in just two years, we’ve won distribution licenses for our own cannabis operations across four states, allowing for up to 11 dispensaries and three cultivation and processing facilities. All with a singular business model centered around best-practices and people.  |
Room 1 |
| 5/2/2019 10:00 AM -to- 10:30 AM | ManifestSeven Sturges Karban ManifestSeven ManifestSeven, Formerly Known as MJIC. To be big, you need to think big, and at ManifestSeven, we’re changing the way legal cannabis gets from A to B. We’re building a “cannabis superhighway” – a fully-licensed logistics network spanning the state of California, and eventually, beyond. ManifestSeven has hubs stretching from Sacramento to San Diego, from the desert to the Pacific, integrating our compliant distribution operations and retail channels into one seamless platform. Whether it’s B2B or B2C, supply chain solutions or on-demand consumer products, ManifestSeven has you covered.  |
Room 1 |
| 5/2/2019 10:30 AM -to- 11:00 AM | FSD Pharma | CSE: HUGE Dr. Raza Bokhari FSD Pharma | CSE: HUGE FSD Pharma is a broadly diversified cannabis company with operations including research and development, cultivation, processing, extraction, and manufacturing. FSD has a "farm to laboratory" vertically integrated operating structure. The farming operation produces raw materials for cannabis products and derivatives. This is achieved through a highly managed supply chain process which yields maximum high quality product efficiently.  |
Room 1 |
| 5/2/2019 11:00 AM -to- 11:30 AM | Isracann Biosciences Sean Bromley Isracann Biosciences Isracann, Israel’s first pure-play cannabis firm, is focused on becoming a premier, low-cost cannabis producer. Isracann has secured 3 farms in Israel with cultivation licenses totalling 580,000 sq. ft. Located in the cannabis research capital of the world, Isracann has relationships with the research, scientific and medical community to identify opportunities and develop pipeline of drugs and devices. The company is targeting an undersupplied domestic market and anticipates near-term expansion to major European marketplaces.  |
Room 1 |